Any CAH therapy should demonstrate therapeutic effects over the long haul. Can you summarize which end points—glucocorticoid dose stability and lowering, androstenedione reduction, BMI, and others—were maintained over the long term with crinecerfont?
Any CAH therapy should demonstrate therapeutic effects over the long haul. Can you summarize which end points—glucocorticoid dose stability and lowering, androstenedione reduction, BMI, and others—were maintained over the long term with crinecerfont?
Professor of Pharmacology and Internal Medicine Division of Metabolism, Endocrinology, and Diabetes University of Michigan School of Medicine Ann Arbor, Michigan
